Loading data
GPGINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 59.82 m USD | 420.57 m USD | 390.63 m USD | 378.48 m USD | 267.95 m USD |
| Cost of revenue | 31.08 m USD | 201.34 m USD | 181.55 m USD | 158.83 m USD | 123.1 m USD |
| Gross profit | 28.75 m USD | 219.23 m USD | 209.08 m USD | 219.64 m USD | 144.85 m USD |
| Research and development expense | 1.32 m USD | 7.44 m USD | 6.78 m USD | 6.72 m USD | 2.7 m USD |
| Operating profit | -13.73 m USD | 107.62 m USD | 119.09 m USD | 114.9 m USD | 81.43 m USD |
| Profit before tax | -225.78 m USD | -80.98 m USD | 117.08 m USD | 136.18 m USD | 82.56 m USD |
| Income tax expense | 39.03 m USD | 2.19 m USD | 4.56 m USD | 4.36 m USD | -857 k USD |
| Net income (reported basis) | -136.01 m USD | -83.16 m USD | 112.52 m USD | 131.82 m USD | 83.41 m USD |
| Net income attributable to common shareholders | -136.01 m USD | -53.72 m USD | 19.24 m USD | 18.66 m USD | 3.15 m USD |
| Basic earnings per share | -1.23 USD/share | -1.22 USD/share | 1.03 USD/share | 1.21 USD/share | 0.21 USD/share |
| Diluted earnings per share | -1.23 USD/share | -1.22 USD/share | 0.96 USD/share | 1.13 USD/share | 0.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.